Ziran Navid, Hill Suvimol, Wright Mary E, Kovacs Joseph, Robey Pamela Gehron, Wientroub Shlomo, Collins Michael T
Department of Orthopedic Surgery, University of Rochester, Rochester, New York, USA.
Skeletal Radiol. 2002 Dec;31(12):714-9. doi: 10.1007/s00256-002-0552-6. Epub 2002 Aug 15.
Ribbing disease is a rare form of sclerosing dysplasia characterized by benign endosteal and periosteal bone growth confined to the diaphyses of the long bones, usually the tibiae and femora. The onset is usually after puberty and the most common presentation is pain that is usually self-limited, but may progress. The etiology and optimal treatment for the disease are unknown. We present the case of a 39-year-old Hispanic man with clinical and radiological manifestations of Ribbing disease. Radiographs and CT imaging demonstrated typical cortical thickening in the mid-diaphyses of the tibiae bilaterally that correlated with intense tracer uptake on (99m)Tc-MDP bone scans. MRI demonstrated cortical thickening and abnormal marrow signal consistent with marrow edema. Bone marrow edema may explain the pain frequently associated with the disease. Multiple serum and urine markers of bone metabolism were within normal limits. In an effort to ameliorate pain, the patient was treated with the bisphosphonate, pamidronate. In spite of treatment, pain increased, requiring additional and larger doses of analgesics. Serial radiographs, CT, bone scans, and MRI all demonstrated disease progression with pamidronate treatment. In this report we present for the first time the finding of bone marrow edema with MRI as well as disease progression during intravenous pamidronate treatment.
里宾病是一种罕见的骨硬化发育异常,其特征为良性骨内膜和骨膜骨生长,局限于长骨干,通常为胫骨和股骨。发病通常在青春期后,最常见的表现是疼痛,通常为自限性,但可能进展。该病的病因和最佳治疗方法尚不清楚。我们报告一例39岁西班牙裔男性,具有里宾病的临床和影像学表现。X线片和CT成像显示双侧胫骨骨干中部典型的皮质增厚,与(99m)锝-亚甲基二膦酸盐骨扫描上的强烈示踪剂摄取相关。MRI显示皮质增厚和异常骨髓信号,符合骨髓水肿。骨髓水肿可能解释了该病常伴有的疼痛。多种血清和尿液骨代谢标志物均在正常范围内。为缓解疼痛,患者接受了双膦酸盐药物帕米膦酸钠治疗。尽管进行了治疗,疼痛仍加剧,需要增加剂量且加大镇痛药用量。系列X线片、CT、骨扫描和MRI均显示帕米膦酸钠治疗期间疾病进展。在本报告中,我们首次展示了MRI发现的骨髓水肿以及静脉注射帕米膦酸钠治疗期间的疾病进展情况。